A major breakthrough in the clinical approach to type 2 diabetes holds out hope that newly diagnosed individuals can avoid many of the disease’s worst effects for far longer, according to Sir Michael Hirst and Dr. Päivi Maria Paldánius writing in CapX. Based on […]
Tag: drug companies
Protecting IP is critical to the fight against disease
With the world confronting daunting new health challenges, the UN is emphasizing the need to achieve true universal healthcare. That’s a laudable goal worth supporting — but the same can’t be said for the UN and other global organizations frequent support for measures that jeopardize […]